These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 38276986)
1. Peptidic heterodimer-based radiotracer targeting fibroblast activation protein and integrin α Liu K; Jiang T; Rao W; Chen B; Yin X; Xu P; Hu S Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1544-1557. PubMed ID: 38276986 [TBL] [Abstract][Full Text] [Related]
2. A comparison of [ Liu N; Wan Q; Wu X; Zhao T; Jakobsson V; Yuan H; Chen X; Zhang J; Zhang W Eur J Nucl Med Mol Imaging; 2024 May; 51(6):1685-1697. PubMed ID: 38246909 [TBL] [Abstract][Full Text] [Related]
3. Synthesis, preclinical, and initial clinical evaluation of integrin α Wen X; Wang R; Xu P; Shi M; Shang Q; Zeng X; Zeng X; Liu J; Wang X; Zhu Z; Guo Z; Chen X; Zhang J Eur J Nucl Med Mol Imaging; 2024 Jun; 51(7):2023-2035. PubMed ID: 38376806 [TBL] [Abstract][Full Text] [Related]
4. Clinical Evaluation of Zhao L; Wen X; Xu W; Pang Y; Sun L; Wu X; Xu P; Zhang J; Guo Z; Lin Q; Chen X; Chen H J Nucl Med; 2023 Aug; 64(8):1210-1217. PubMed ID: 37142301 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of an Integrin α Gai Y; Jiang Y; Long Y; Sun L; Liu Q; Qin C; Zhang Y; Zeng D; Lan X Mol Pharm; 2020 Jan; 17(1):349-358. PubMed ID: 31829615 [TBL] [Abstract][Full Text] [Related]
6. In Vivo Characterization of 4 Lobeek D; Franssen GM; Ma MT; Wester HJ; Decristoforo C; Oyen WJG; Boerman OC; Terry SYA; Rijpkema M J Nucl Med; 2018 Aug; 59(8):1296-1301. PubMed ID: 29626124 [TBL] [Abstract][Full Text] [Related]
7. (68)Ga-labeled multimeric RGD peptides for microPET imaging of integrin alpha(v)beta (3) expression. Li ZB; Chen K; Chen X Eur J Nucl Med Mol Imaging; 2008 Jun; 35(6):1100-8. PubMed ID: 18204838 [TBL] [Abstract][Full Text] [Related]
8. Synthesis, preclinical evaluation and radiation dosimetry of a dual targeting PET tracer [ Zang J; Wen X; Lin R; Zeng X; Wang C; Shi M; Zeng X; Zhang J; Wu X; Zhang X; Miao W; Xu P; Guo Z; Zhang J; Chen X Theranostics; 2022; 12(16):7180-7190. PubMed ID: 36276644 [TBL] [Abstract][Full Text] [Related]
9. Preclinical evaluation of a dual sstr2 and integrin α Liu B; Zhang Z; Wang H; Yao S Bioorg Med Chem; 2019 Nov; 27(21):115094. PubMed ID: 31540828 [TBL] [Abstract][Full Text] [Related]
10. Clinical Translation of a Dual Integrin αvβ3- and Gastrin-Releasing Peptide Receptor-Targeting PET Radiotracer, 68Ga-BBN-RGD. Zhang J; Niu G; Lang L; Li F; Fan X; Yan X; Yao S; Yan W; Huo L; Chen L; Li Z; Zhu Z; Chen X J Nucl Med; 2017 Feb; 58(2):228-234. PubMed ID: 27493267 [TBL] [Abstract][Full Text] [Related]
11. Chen CJ; Chan CH; Lin KL; Chen JH; Tseng CH; Wang PY; Chien CY; Yu HM; Lin WJ Nucl Med Biol; 2019; 68-69():22-30. PubMed ID: 30578136 [TBL] [Abstract][Full Text] [Related]
12. Huang J; Zhang X; Liu Q; Gong F; Huang Y; Huang S; Fu L; Tang G J Med Chem; 2024 Oct; 67(19):17785-17795. PubMed ID: 39321030 [TBL] [Abstract][Full Text] [Related]
14. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression. Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848 [TBL] [Abstract][Full Text] [Related]
15. (68)Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin alphavbeta3 PET imaging. Liu Z; Niu G; Shi J; Liu S; Wang F; Liu S; Chen X Eur J Nucl Med Mol Imaging; 2009 Jun; 36(6):947-57. PubMed ID: 19159928 [TBL] [Abstract][Full Text] [Related]
16. Development, preclinical evaluation and preliminary dosimetry profiling of SB03178, a first-of-its-kind benzo[h]quinoline-based fibroblast activation protein-α-targeted radiotheranostic for cancer imaging and therapy. Bendre S; Merkens H; Kuo HT; Ng P; Wong AAWL; Lau WS; Zhang Z; Kurkowska S; Chen CC; Uribe C; Bénard F; Lin KS Eur J Med Chem; 2024 Mar; 268():116238. PubMed ID: 38367492 [TBL] [Abstract][Full Text] [Related]
17. Synthesis and preclinical evaluation of a heterodimeric radioligand targeting fibroblast activation protein and integrin-α Yan Q; Zhong J; Liu Y; Peng S; Feng P; Zhong Y; Hu K Eur J Med Chem; 2023 May; 251():115279. PubMed ID: 36931125 [TBL] [Abstract][Full Text] [Related]
18. Comparison of Ga-68-Labeled Fusarinine C-Based Multivalent RGD Conjugates and [(68)Ga]NODAGA-RGD-In Vivo Imaging Studies in Human Xenograft Tumors. Zhai C; Franssen GM; Petrik M; Laverman P; Summer D; Rangger C; Haubner R; Haas H; Decristoforo C Mol Imaging Biol; 2016 Oct; 18(5):758-67. PubMed ID: 26905697 [TBL] [Abstract][Full Text] [Related]
19. (18)F, (64)Cu, and (68)Ga labeled RGD-bombesin heterodimeric peptides for PET imaging of breast cancer. Liu Z; Yan Y; Liu S; Wang F; Chen X Bioconjug Chem; 2009 May; 20(5):1016-25. PubMed ID: 20540537 [TBL] [Abstract][Full Text] [Related]
20. (68)Ga-labeled NOTA-RGD-BBN peptide for dual integrin and GRPR-targeted tumor imaging. Liu Z; Niu G; Wang F; Chen X Eur J Nucl Med Mol Imaging; 2009 Sep; 36(9):1483-94. PubMed ID: 19360404 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]